297 related articles for article (PubMed ID: 16259009)
1. Destructive potential of the aspartyl protease cathepsin D in MHC class II-restricted antigen processing.
Moss CX; Villadangos JA; Watts C
Eur J Immunol; 2005 Dec; 35(12):3442-51. PubMed ID: 16259009
[TBL] [Abstract][Full Text] [Related]
2. Antigen processing by endosomal proteases determines which sites of sperm-whale myoglobin are eventually recognized by T cells.
Van Noort JM; Boon J; Van der Drift AC; Wagenaar JP; Boots AM; Boog CJ
Eur J Immunol; 1991 Sep; 21(9):1989-96. PubMed ID: 1716206
[TBL] [Abstract][Full Text] [Related]
3. Destructive proteolysis by cysteine proteases in antigen presentation of ovalbumin.
Rodriguez GM; Diment S
Eur J Immunol; 1995 Jul; 25(7):1823-7. PubMed ID: 7621859
[TBL] [Abstract][Full Text] [Related]
4. Wortmannin, an inhibitor of phospholipase D activation, selectively blocks major histocompatibility complex class II-restricted antigen presentation.
Carrasco-Marín E; Alvarez-Domínguez C; Leyva-Cobián F
Eur J Immunol; 1994 Sep; 24(9):2031-9. PubMed ID: 8088323
[TBL] [Abstract][Full Text] [Related]
5. Pepstatin A-sensitive aspartic proteases in lysosome are involved in degradation of the invariant chain and antigen-processing in antigen presenting cells of mice infected with Leishmania major.
Zhang T; Maekawa Y; Yasutomo K; Ishikawa H; Fawzy Nashed B; Dainichi T; Hisaeda H; Sakai T; Kasai M; Mizuochi T; Asao T; Katunuma N; Himeno K
Biochem Biophys Res Commun; 2000 Sep; 276(2):693-701. PubMed ID: 11027533
[TBL] [Abstract][Full Text] [Related]
6. Fc epsilon receptor I on dendritic cells delivers IgE-bound multivalent antigens into a cathepsin S-dependent pathway of MHC class II presentation.
Maurer D; Fiebiger E; Reininger B; Ebner C; Petzelbauer P; Shi GP; Chapman HA; Stingl G
J Immunol; 1998 Sep; 161(6):2731-9. PubMed ID: 9743330
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of thymus-independent type 2 antigens on MHC class II-restricted antigen presentation: comparative analysis of carbohydrate structures and the antigen presenting cell.
González-Fernández M; Carrasco-Marín E; Alvarez-Domínguez C; Outschoorn IM; Leyva-Cobián F
Cell Immunol; 1997 Feb; 176(1):1-13. PubMed ID: 9070312
[TBL] [Abstract][Full Text] [Related]
8. Role of cathepsin D in antigen presentation of ovalbumin.
Rodriguez GM; Diment S
J Immunol; 1992 Nov; 149(9):2894-8. PubMed ID: 1328388
[TBL] [Abstract][Full Text] [Related]
9. Presentation on class II MHC molecules of endogenous lysozyme targeted to the endocytic pathway.
Parra-López CA; Lindner R; Vidavsky I; Gross M; Unanue ER
J Immunol; 1997 Mar; 158(6):2670-9. PubMed ID: 9058800
[TBL] [Abstract][Full Text] [Related]
10. The endo/lysosomal protease cathepsin B is able to process conalbumin fragments for presentation to T cells.
Gradehandt G; Ruede E
Immunology; 1991 Nov; 74(3):393-8. PubMed ID: 1769688
[TBL] [Abstract][Full Text] [Related]
11. T cell clones to two major T cell epitopes of myoglobin: effect of I-A/I-E restriction on epitope dominance.
Berkower I; Kawamura H; Matis LA; Berzofsky JA
J Immunol; 1985 Oct; 135(4):2628-34. PubMed ID: 2411806
[TBL] [Abstract][Full Text] [Related]
12. Asparaginyl endopeptidase: case history of a class II MHC compartment protease.
Watts C; Matthews SP; Mazzeo D; Manoury B; Moss CX
Immunol Rev; 2005 Oct; 207():218-28. PubMed ID: 16181339
[TBL] [Abstract][Full Text] [Related]
13. MHC Class II levels and intracellular localization in human dendritic cells are regulated by calmodulin kinase II.
Herrmann TL; Agrawal RS; Connolly SF; McCaffrey RL; Schlomann J; Kusner DJ
J Leukoc Biol; 2007 Sep; 82(3):686-99. PubMed ID: 17586661
[TBL] [Abstract][Full Text] [Related]
14. Identification of proteases that process distinct epitopes on the same protein.
Takahashi H; Cease KB; Berzofsky JA
J Immunol; 1989 Apr; 142(7):2221-9. PubMed ID: 2466893
[TBL] [Abstract][Full Text] [Related]
15. Influenza A virus elevates active cathepsin B in primary murine DC.
Burster T; Giffon T; Dahl ME; Björck P; Bogyo M; Weber E; Mahmood K; Lewis DB; Mellins ED
Int Immunol; 2007 May; 19(5):645-55. PubMed ID: 17446210
[TBL] [Abstract][Full Text] [Related]
16. Auranofin, an immunosuppressive drug, inhibits MHC class I and MHC class II pathways of antigen presentation in dendritic cells.
Han S; Kim K; Song Y; Kim H; Kwon J; Lee YH; Lee CK; Lee SJ; Ha N; Kim K
Arch Pharm Res; 2008 Mar; 31(3):370-6. PubMed ID: 18409052
[TBL] [Abstract][Full Text] [Related]
17. Glutathione depletion reveals impairment of antigen processing and inhibition of cathepsin activity by nitric oxide in antigen-presenting cells.
Lemaire G; Guittet O; Vesin MF; Lepoivre M; Cottet MH
Mol Immunol; 2009 Mar; 46(6):1100-8. PubMed ID: 19095306
[TBL] [Abstract][Full Text] [Related]
18. The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules.
Watts C
Nat Immunol; 2004 Jul; 5(7):685-92. PubMed ID: 15224094
[TBL] [Abstract][Full Text] [Related]
19. Cloning of a novel MHC-encoded serine peptidase highly expressed by cortical epithelial cells of the thymus.
Bowlus CL; Ahn J; Chu T; Gruen JR
Cell Immunol; 1999 Sep; 196(2):80-6. PubMed ID: 10527559
[TBL] [Abstract][Full Text] [Related]
20. Natural processing sites for human cathepsin E and cathepsin D in tetanus toxin: implications for T cell epitope generation.
Hewitt EW; Treumann A; Morrice N; Tatnell PJ; Kay J; Watts C
J Immunol; 1997 Nov; 159(10):4693-9. PubMed ID: 9366392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
